Search Results

An Interview With Christoph A. Nienaber, MD, PhD, FESC, FAHA

Prof. Nienaber discusses current and emerging methods for aortic dissection care, as well as the recent work of the International Registry of Aortic Dissection (IRAD) organization.

Type B Aortic Dissection: Perspectives, Techniques, and Decision-Making

By Christoph A. Nienaber, MD, PhD, FESC, FAHA, and Grace J. Wang, MD, MSCE, FACS

Analyzing the Impact of INSTEAD at 5 Years

Matt M. Thompson, MD, FRCS, discusses the long-term results of INSTEAD with Principal Investigator Christoph A. Nienaber, MD, and their influence on treatment protocols for aortic dissection.

Dissection Retrospective: Progress Since the INSTEAD Trial

Lessons learned from the first randomized trial comparing TEVAR and optimal medical therapy for type B aortic dissection.

By Christoph A. Nienaber, MD, PhD, FESC, FAHA

Ask the Experts: Should Clinically Asymptomatic Patients With Acute Type B Dissections and Radiographic Malperfusion Be Treated?

With Wilson Szeto, MD; Ibrahim Sultan, MD; Frank R. Arko III, MD; John R. Frederick, MD; Jocelyn K. Ballast, BA; and Christoph A. Nienaber, MD, PhD, FESC, FAHA

Panel Discussion: Decision-Making for Type B Aortic Dissection

Device choices and approaches to de novo TBAD presenting with malperfusion or an enlarging thoracoabdominal aortic diameter after TEVAR, thoughts on whether to intervene on the false lumen, and surveillance protocols after TEVAR.

With Tilo Kölbel, MD, PhD; Tara M. Mastracci, MD, FRCSC; Christoph A. Nienaber, MD, PhD, FESC, FAHA; Germano Melissano, MD; Daniele Mascia, MD; and Eric E. Roselli, MD, FACS

Type B Aortic Dissection

Are aortic endografts changing the treatment paradigm?

By Ross Milner, MD

Advances in Treating Thoracic Aortic Dissection

By Matt M. Thompson, MD, FRCS, and Michael D. Dake, MD

All Eyes on TEVAR

By Takao Ohki, MD, PhD

CLI: In Focus

By Jos C. van den Berg, MD, PhD, and Jihad A. Mustapha, MD